ondansetron has been researched along with Myoclonic Jerk in 3 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Naguy, A | 1 |
Kolli, V | 1 |
Addula, M | 1 |
Kumar, N | 1 |
Hu, WT | 1 |
3 other studies available for ondansetron and Myoclonic Jerk
Article | Year |
---|---|
Ondansetron-Induced Myoclonus With Escitalopram and Highly Active Antiretroviral Therapy: A Closer Look at 5-HT3 Receptors.
Topics: Antiretroviral Therapy, Highly Active; Citalopram; Drug Interactions; Humans; Myoclonus; Ondansetron | 2020 |
Ondansetron-Induced Myoclonus With Escitalopram and HAART: Role of Drug Interactions.
Topics: Adult; Anti-Anxiety Agents; Antiretroviral Therapy, Highly Active; Anxiety Disorders; Citalopram; Dr | 2019 |
Extrapyramidal reaction to ondansetron and propofol.
Topics: Adult; Anesthesia Recovery Period; Anesthetics, Intravenous; Antiemetics; Basal Ganglia Diseases; Di | 2009 |